Designing a COVID-19 Vaccine That Maintains Efficacy Against All Variants

A major step has apparently been achieved to develop a COVID-19 vaccine designed to handle any present or future variants of the coronavirus. RT reports on a study published on Nov. 30, by a collection of Chinese scientists, showing that monoclonal antibody 35B5 was able to neutralize all variants, both in test-tube experiments and with “humanized” mice.